AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ZIDOVUDINE+ LAMIVUDINE
9 registrations across 3 African markets— 6 active
Markets with ZIDOVUDINE+ LAMIVUDINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ZIDOVUDINE+LAMIVUDINE 300MG/150MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2024 |
| ASPEN-LAMZID COMBINATION PRODUCT TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2014 |
| ZIDOLAM COMBINATION PRODUCT TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2012 |
| ZIDOVUDINE+
LAMIVUDINE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | CIPLA LTD. | active | — |
| ZIDOVUDINE+
LAMIVUDINE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | CIPLA LTD. | active | — |
| Avocomb Tablets | 🇹🇿Tanzania | Sun Pharmaceutical Industries Ltd | active | — |
| ZIDOVUDINE+
LAMIVUDINE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | CIPLA LTD. | active | — |
| Lamivudine and Zidovudine Tablets | 🇹🇿Tanzania | Mylan Laboratories Limited | active | — |
| ZIDOVUDINE+
LAMIVUDINE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | CIPLA LTD. | active | — |
ZIDOVUDINE+ LAMIVUDINE in Africa — Regulatory Overview
ZIDOVUDINE+ LAMIVUDINE is registered across 3 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Malawi, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 6 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.